orforglipron semaglutide comparison Efficacy and safety of once-daily oral compared with oral in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial Orforglipron vs Oral Semaglutide: Update

Rong X et al

Everything happens online

GLP-1 receptor agonists have demonstrated measurable triglyceride-lowering effects in clinical trials, with reductions ranging from 15-30% depending on baseline lipid status and medication type

With the same side effects, both forms can be beneficial in reducing weight, and the decision must be in consultation with your healthcare provider.

(3) This phase lasts for two weeks and focuses on 15 habits, calling for you to add five healthy habits, break five unhealthy habits, and adopt five bonus healthy habits

Semaglutide and tirzepatide are FDA-approved prescription drugs, manufactured and distributed under controlled supply chains for clinical use